Epoprostenol

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Flolan (GSK); Veletri (Actelion)
  • INDICATIONS: Pulmonary arterial hypertension
  • CLASS: Peripheral vasodilator
  • HALF-LIFE: 6 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Anticoagulants, Antihypertensives, Diuretics, Vasodilators

PREGNANCY CATEGORY: B

NOTE

Contra-indicated in patients with heart failure induced by reduced left ventricular ejection fraction.

Our database has 61 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RESPIRATORY.
OTHER.


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top